Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians

Human Molecular Genetics

Volumn 10, Issue 8, 2001, Pages 815-824

  Ogorelkova, Miroslava ^a   Kraft, Hans G ^a   Ehnholm, Christian ^b   Utermann, Gerd ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; GENE PRODUCT; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

AFRICA; ALLELE; ARTICLE; ATHEROSCLEROSIS; CAUCASIAN; CONTROLLED STUDY; ETHNIC GROUP; EXON; GENE LOCUS; GENETIC CODE; GENETIC SCREENING; HUMAN; HUMAN EXPERIMENT; INTRON; KRINGLE DOMAIN; LIPOPROTEIN BLOOD LEVEL; NEGRO; NORMAL HUMAN; POPULATION GENETICS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0035311403     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.8.815     Document Type: Article

References (56)

1. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen
2. Lipoprotein(a)
3. Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African Populations: The distribution of null alleles is non-random
4. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus
5. Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans: The CARDIA Study
6. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups
7. The apolipoprotein(a) gene: A transcribed hypervariable locus controlling plasma lipoprotein(a) concentration
8. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations
9. Genetic variation in lipoprotein(a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein(a) gene locus
10. The apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans
11. Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians
12. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma
13. Genetic architecture and evolution of the lipoprotein(a) trait
14. The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells
15. Molecular basis for "null" lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon
16. Influence of allelic variation on apolipoprotein(a) folding in the endoplasmic reticulum
17. Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells
18. Sequence polymorphisms in the apolipoprotein(a) gene
19. C/T polymorphism in the 5′ untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation
20. Significance of glomerular deposition of apolipoprotein (a) in various glomerulopathies
21. Significant impact of the +93 C/T polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in Africans but not in Caucasians: Confounding effect of linkage disequilibrium
22. Molecular basis of congenital Lp(a) deficiency: A frequent apo(a) "null" mutation in Caucasians
23. A pentanucleotide repeat polymorphism in the 5′ control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians
24. Sequence microheterogeneity in apolipoprotein(a) gene repeats and the relationship to plasma Lp(a) levels
25. Polymorphisms in the apolipoprotein(a) gene and their relationship to allele size and plasma lipoprotein(a) concentration
26. The seventh myth of lipoprotein(a): Where and how is it assembled
27. A two-step model for lipoprotein(a) formation
28. Inhibitors for the in vitro assembly of Lp(a)
29. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate no covalent association of apolipoprotein(a) with apolipoprotein B-100
30. Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly
31. Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a)
32. Cloning, expression, and characterization of human apolipoprotein(a) Kringle IV37
33. Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice
34. Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus
35. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
36. The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin
37. A quantitative immunoassay for the lysine-binding function of lipoprotein(a). Application to recombinant apo(a) and lipoprotein(a) in plasma
38. A single point mutation (Trp72→Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a)
39. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): An Asp57→Asn mutation in kringle IV-10 is associated with poor fibrin binding
40. Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis
41. Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system
42. Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes
43. Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein(a) size polymorphism
44. The identification and significance of a Thr→Pro polymorphism in kringle IV type 8 of apolipoprotein(a)
45. Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apo(a) kringle IV-10 expressed in E coli and CHO cells
46. Ten allelic apolipoprotein[a] 5′ flanking fragments exhibit comparable promoter activities in HepG2 cells
47. The identification of polymorphisms in the coding region of the apolipoprotein(a) gene-association with earlier identified polymorphic sites and influence on the lipoprotein(a) concentration
48. Characterization of single-nucleotide polymorphisms in coding regions of human genes
49. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis
50. The role of apo-(a) kringle-IVs in the assembly of lipoprotein-(a)
51. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a)
52. Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation
53. Genomic structure and organization of kringles type 3 to 10 of the apolipoprotein(a) gene in 6q26-27
54. The number of kringle IV repeats 3-10 is invariable in the human apo(a) gene
55. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis